Navigation Links
Defensive Medicine Drives Wedge Between Patients/Physicians

According to a new national survey of physicians by Jackson Healthcare, 72 percent of physicians report that the practice of defensive medicine negatively impacts patient care. Sixty-seven percent report that defensive medicine comes between the doctor and patient.

Atlanta, GA (Vocus) April 21, 2010 -- According to a new national survey of physicians by Jackson Healthcare, 72 percent of physicians report that the practice of defensive medicine negatively impacts patient care. Sixty-seven percent report that defensive medicine comes between the doctor and patient.

This survey is the third in a series of physician surveys by Jackson Healthcare to qualify and quantify the impact lawsuits have on medical care in the U.S. It follows Jackson’s recent quantifying the cost of defensive medicine, in which physicians estimate $650 billion to $850 billion is spent each year on defensive medicine. Defensive medicine refers to the unnecessary tests and treatments that physicians order to avoid lawsuits.

“Nothing should come between physicians and patients, especially third parties like government bureaucrats and attorneys who have no medical training,” said Richard Jackson, chairman and chief executive officer of Jackson Healthcare. “The physician/patient relationship is sacred and must be protected to the benefit of our physicians and us, their patients.”

Additionally, 75 percent of respondents believe defensive medicine will decrease the number of physicians in the U.S., perpetuating an existing physician shortage, and 87 percent of current residents and fellows reported that they were taught to practice defensive medicine. This has implications for the next generation of physicians, the future cost of healthcare and patient access to the care they need.

According to Jackson, “Without radical medical malpractice reform that gets at the root problem, not only will costs continue to climb, but our survey suggests that access, quality and innovation will continue to be limited to certain patients. We need a balanced, common sense approach that guarantees patients their rights without undermining their care.”

A summary of the new survey findings can be found in Jackson Healthcare’s online media room at Market Research.

For more information contact Bob Schlotman at 770-643-5697 at Jackson Healthcare.

About Jackson Healthcare
Founded by the healthcare innovator Richard Jackson, Jackson Healthcare serves more than two million patients in nearly one thousand hospitals each year. The Jackson family of companies provides physician and clinician staffing, anesthesia management, hospital management and healthcare information technology solutions proven to improve clinical and financial outcomes, as well as increase operational efficiency. Jackson Healthcare has earned national media coverage for its physician polls and champions local and international charitable work. In addition, Jackson has been recognized as one of the largest and fastest growing staffing companies in the country by the Inc. Magazine, Atlanta Business Chronicle, Georgia Trend and Staffing Industry Analysts. For more information about Jackson and its companies, visit Jackson Healthcare. Jackson's research reports are available online at Market Research.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New Gallup Poll Quantifies U.S. Physician Opinions on the Scope of Defensive Medicine Practices
2. What's the Cost of Defensive Medicine?
3. Tort Reform Does Not Eliminate Defensive Medicine Practices, Study Finds
4. Recent Book Moves Beyond Defensive Medicine, Tackles Entitlement Reform
5. New Speakers Announced for the 2010 Personalized Medicine Partnerships Conference
6. Biofeedback Now Seen as Regular Medicine
7. UM School of Medicine scientists find new malaria vaccine is safe and protective in children
8. Springer publishes new journal in predictive, preventive and personalized medicine
9. Nuclear Medicine at Summit Medical Group Earns ACR Re-Accreditation
10. Oakland University William Beaumont School of Medicine Reaches Development Milestone
11. Statement from the Consumer Healthcare Products Association on Mississippi Bill that Limits Consumer Access to Cold and Allergy Medicines Containing Pseudoephedrine by Requiring a Prescription
Post Your Comments:
Related Image:
Defensive Medicine Drives Wedge Between Patients/Physicians
(Date:12/1/2015)... ... 2015 , ... Speech and physical therapies are traditionally conducted ... and under the right circumstances, these practices can be merged. This combination ... his or her therapeutic sessions, as well as gives the physical and speech ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... Libertyville, IL (PRWEB) , ... December 01, 2015 ... ... catheters, keeping their independence is everything. That is why Hollister Incorporated has launched ... excited to offer this next product in the VaPro touch free catheter portfolio,” ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of ... latest addition to the devices for sale in the United States. Clarity is ... long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to own ...
(Date:12/1/2015)... , ... December 01, 2015 , ... With FCPX ... and with full control over customization, the possibilities are truly endless, all with a ... randomization, overlay depth position, vertical flip, horizontal flip, depth of field and more, all ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel ... the company will present at the LD Micro Main Event. ... Sunset Boulevard Hotel in Los Angeles, CA. ... present on Thursday, December 3, at 9:00 am Pacific time ... at least 10 minutes prior to the start of the ...
(Date:12/1/2015)... Dec. 1, 2015   MabVax Therapeutics Holdings, Inc ... announces it has filed an Investigational New Drug Application ... for the Company,s lead fully human antibody product HuMab ... MabVax plans to initiate the Phase I clinical trial ... --> The planned Phase I trial will ...
(Date:12/1/2015)... 2015   Craneware, Inc ., the healthcare ... announced the company will showcase a new version ... solution at the American Society for Health-System ... The new features are focused on simplifying and ... managing enterprise-wide pharmacy charges to ensure compliance and ...
Breaking Medicine Technology: